Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Clinical trial NCT01349933 · COMPLETED

Trial details

NCT number: NCT01349933
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx

Start date: 2011-04-01
Primary completion: 2013-10-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.